2023 Annual Meeting | C47 - Clinical Pearls in Autoimmune Neurology: Real-world Cases
01:00 PM - 01:05 PM EST | Introduction |
Session Aims and Outline
Sarosh R. Irani, MD, PhD, FRCP, FEAN |
01:05 PM - 01:35 PM EST | Speaker |
Case-based Pearls and Errors in Diagnosing Demyelinating Conditions - MS, MOGAD, NMOSD and More
Brian G. Weinshenker, MD, FAAN |
01:35 PM - 01:45 PM EST | Q&A |
Questions and Answers
Brian G. Weinshenker, MD, FAAN |
01:45 PM - 02:10 PM EST | Speaker |
Case-based Pearls and Errors in Diagnosing Autoimmune Encephalitis and Related Syndromes
Sarosh R. Irani, MD, PhD, FRCP, FEAN |
02:10 PM - 02:20 PM EST | Q&A |
Questions and Answers
Sarosh R. Irani, MD, PhD, FRCP, FEAN |
02:20 PM - 02:45 PM EST | Speaker |
Case-based Pearls and Errors in Diagnosing Emerging Autoimmune Peripheral Nerve and Muscle Conditions
Divyanshu Dubey, MD, FAAN |
02:45 PM - 02:55 PM EST | Q&A |
Questions and Answers
Divyanshu Dubey, MD, FAAN |
02:55 PM - 03:00 PM EST | Closing Remarks |
Review of Aims and Closing Remarks
Sarosh R. Irani, MD, PhD, FRCP, FEAN |
Sarosh R. Irani, MD, PhD, FRCP, FEAN | Dr. Irani has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for AZ, Roche, Cerebral therapeutics, Biogen, Amgen, Argenex, Clarivate, IQVIA, BioHaven therapeutics.. Dr. Irani has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Brain. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care. |
Brian G. Weinshenker, MD, FAAN | Dr. Weinshenker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CANbridge Pharmaceuticals. Dr. Weinshenker has received personal compensation in the range of $0-$499 for serving as a Consultant for CALIBR. Dr. Weinshenker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Group (Chugai, Genentech, Roche). Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharmaceuticals. Dr. Weinshenker has received research support from Guthy Jackson Charitable Foundation. Dr. Weinshenker has received intellectual property interests from a discovery or technology relating to health care. |
Divyanshu Dubey, MD, FAAN | The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from UCB. Dr. Dubey has received research support from David J. Tomassoni ALS Research Grant Program . Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. |